Highly Scalable, Wearable Surface‐Enhanced Raman Spectroscopy

The last two decades have witnessed a dramatic growth of wearable sensor technology, mainly represented by flexible, stretchable, on-skin electronic sensors that provide rich information of the wearer's health conditions and surroundings. A recent breakthrough in the field is the development of wearable chemical sensors based on surface-enhanced Raman spectroscopy (SERS) that can detect molecular fingerprints universally, sensitively, and noninvasively. However, while their sensing properties are excellent, these sensors are not scalable for widespread use beyond small-scale human health monitoring due to their cumbersome fabrication process and limited multifunctional sensing capabilities. Here, a highly scalable, wearable SERS sensor is demonstrated based on an easy-to-fabricate, low-cost, ultrathin, flexible, stretchable, adhesive, and biointegratable gold nanomesh. It can be fabricated in any shape and worn on virtually any surface for label-free, large-scale, in situ sensing of diverse analytes from low to high concentrations (10–106 × 10−9 m). To show the practical utility of the wearable SERS sensor, the sensor is tested for the detection of sweat biomarkers, drugs of abuse, and microplastics. This wearable SERS sensor represents a significant step toward the generalizability and practicality of wearable sensing technology

Neuroanatomical Study of the A11 Diencephalospinal Pathway in the Non-Human Primate

BACKGROUND: The A11 diencephalospinal pathway is crucial for sensorimotor integration and pain control at the spinal cord level. When disrupted, it is thought to be involved in numerous painful conditions such as restless legs syndrome and migraine. Its anatomical organization, however, remains largely unknown in the non-human primate (NHP). We therefore characterized the anatomy of this pathway in the NHP. METHODS AND FINDINGS: In situ hybridization of spinal dopamine receptors showed that D1 receptor mRNA is absent while D2 and D5 receptor mRNAs are mainly expressed in the dorsal horn and D3 receptor mRNA in both the dorsal and ventral horns. Unilateral injections of the retrograde tracer Fluoro-Gold (FG) into the cervical spinal enlargement labeled A11 hypothalamic neurons quasi-exclusively among dopamine areas. Detailed immunohistochemical analysis suggested that these FG-labeled A11 neurons are tyrosine hydroxylase-positive but dopa-decarboxylase and dopamine transporter-negative, suggestive of a L-DOPAergic nucleus. Stereological cell count of A11 neurons revealed that this group is composed by 4002±501 neurons per side. A 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) intoxication with subsequent development of a parkinsonian syndrome produced a 50% neuronal cell loss in the A11 group. CONCLUSION: The diencephalic A11 area could be the major source of L-DOPA in the NHP spinal cord, where it may play a role in the modulation of sensorimotor integration through D2 and D3 receptors either directly or indirectly via dopamine formation in spinal dopa-decarboxylase-positives cells

Distribution of central catecholaminergic neurons: a comparison between ungulates, humans and other species

In ungulates and primates, the distribution of central catecholaminergic neurons identified using antibodies raised against catecholamine synthesizing enzymes and catecholamines themselves, shows many differences if compared to rats. Catecholaminergic neurons are more loosely clustered in ungulates and primates than in rat. In the medulla oblongata, the density of noradrenergicladrenergic neurons is lower in ungulates than in other species and, particularly in sheep, the adrenergic group C1 is not observed. The noradrenergic neurons of the locus coeruleus are present in a larger area in ungulates than in rodents. In the hypothalamus, the density of dopamine neurons is lower in ungulates and primates than in rodents. In the rostra1 hypothalamus of ungulates, the dorsal part of the group A14 is missing, and these species present only the ventral part of the group A15. In primates the group A15 extends into the supraoptic and paraventricular nuclei which have large tyrosine hydroxylase-immunoreactive (TH-IR) neurons not observed in other species. In addition, in all studied species, not all cells expressing catecholamine synthesizing enzymes also express catecholamines, as found in some TH-IR neurons in the arcuate nucleus, thereby demonstrating the necessity of using different markers to ascertain the true catecholaminergic nature of labeled neurons. These anatomical differences between species show the difficulty in extrapolating the distribution of catecholamine neurons from one species to another and may be related to adaptative physiological differences between mammals